title: [Cushing's disease in a psychiatric setting].
authors.affiliation: Service de psychiatrie « A », CHU Hédi Chaker, route El Ain, 3089 Sfax, Tunisie. Electronic address: sana_ellini@yahoo.fr.
authors.forename: S
authors.initials: S
authors.lastname: Ellini
authors.affiliation: Service de psychiatrie « A », CHU Hédi Chaker, route El Ain, 3089 Sfax, Tunisie.
authors.forename: I
authors.initials: I
authors.lastname: Feki
authors.affiliation: Service de psychiatrie « A », CHU Hédi Chaker, route El Ain, 3089 Sfax, Tunisie.
authors.forename: N
authors.initials: N
authors.lastname: Smaoui
authors.affiliation: Service de psychiatrie « A », CHU Hédi Chaker, route El Ain, 3089 Sfax, Tunisie.
authors.forename: I
authors.initials: I
authors.lastname: Jamoussi
authors.affiliation: Service de psychiatrie « A », CHU Hédi Chaker, route El Ain, 3089 Sfax, Tunisie.
authors.forename: J
authors.initials: J
authors.lastname: Masmoudi
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008140:Lorazepam / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D001523:Mental Disorders / Q000150:complications* / Q000628:therapy*; D000077152:Olanzapine; D047748:Pituitary ACTH Hypersecretion / Q000150:complications* / Q000000981:diagnostic imaging / Q000628:therapy*
chemical_list: D014150:Antipsychotic Agents; D006993:Hypnotics and Sedatives; D001569:Benzodiazepines; D000077152:Olanzapine; D008140:Lorazepam